New vaccine effective in preventing TB in African patients with HIV infection – PhysOrg
Investigators from Dartmouth Medical School (DMS) have reported results of a clinical trial showing that a new vaccine against tuberculosis, Mycobacterium vaccae (MV), is effective in preventing tuberculosis in people with HIV infection. The DarDar Health Study, named for Dartmouth and Dar es Salaam
Related posts:
- South Africa : Focus ‘Must Be On HIV Prevention’ – AllAfrica.com
- USA Ban on HIV-Positive Visitors, Immigrants Expires
- Charging less for more effective treatments could reduce health care … – Genetic Engineering News
- AIDS Vaccine Trial Cancelled
- Report: Tuberculosis Is ‘Neglected Sister’ of Health … – AOL News

Leave a Comments »
Trackback | RSS 2.0
no comments yet - be the first?